Sun Pharma recalls 10 eye drop brands sold in India after contamination concerns were flagged, according to reports citing the company’s action. The recalls are intended to remove potentially affected products from circulation while safety checks continue. Multiple experts quoted in coverage warn that contaminated eye drops can lead to eye infections and, in some cases, complications that may affect vision. The recall has also renewed attention on pharmaceutical quality and safety standards for ophthalmic medicines, which are used directly on the eye and therefore require stringent manufacturing and storage controls. While the reports focus on the health risks associated with unsafe eye drops, they do not specify the exact contaminants or the findings behind the decision in the provided accounts. The company’s move is presented as a precautionary step in response to the contamination scare, with the implication that consumers should avoid using the listed products and seek guidance from official channels regarding replacements or refunds.